Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(1.08)
# 2057
Out of 5,358 analysts
104
Total ratings
45.76%
Success rate
3.06%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
UTHR United Therapeutics | Initiates Coverage On: Overweight | 405 | 325.81 | 24.31% | 1 | Jun 2, 2025 | |
VNDA Vanda Pharmaceutical... | Assumes: Overweight | 13 | 4.62 | 181.39% | 1 | May 14, 2025 | |
BMRN Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 56.67 | 58.81% | 15 | Feb 20, 2025 | |
VRTX Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 450.33 | 6.59% | 22 | Feb 11, 2025 | |
BMY Bristol-Myers Squibb | Maintains: Neutral | 50 55 | 48.41 | 13.61% | 9 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 80 | 112.44 | -28.85% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 493.12 | 105.83% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 290.34 | 39.49% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 300.77 | -26.85% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 8.18 | 22.25% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 4.38 | 48.4% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 41.92 | 71.76% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | n/a | n/a | 2 | Feb 23, 2023 |